Pelvic Lymph Node Irradiation Including Pararectal Sentinel Nodes for Prostate Cancer Patients: Treatment Optimization Comparing Intensity Modulated X-rays, Volumetric Modulated Arc Therapy, and Intensity Modulated Proton Therapy

被引:15
|
作者
Vees, Hansjorg [1 ]
Dipasquale, Giovanna [1 ]
Nouet, Philippe [1 ]
Zilli, Thomas [1 ]
Cozzi, Luca [2 ]
Miralbell, Raymond [1 ]
机构
[1] Univ Hosp Geneva, Serv Radiat Oncol, Geneva, Switzerland
[2] Oncol Inst Southern Switzerland, Med Phys Unit, Bellinzona, Switzerland
关键词
IMXT; IMPT; Prostate cancer; Sentinel node; SPECT; VMAT; RADIATION-THERAPY; CONFORMAL RADIOTHERAPY; DOSE DISTRIBUTIONS; URINARY TOXICITY; PHOTON; IMRT; CONSENSUS; DELIVERY; RAPIDARC;
D O I
10.7785/tcrt.2012.500405
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We aimed to assess the dosimetric impact of advanced delivery radiotherapy techniques using either intensity modulated x-ray beams (IMXT), volumetric modulated arc therapy (VMAT), or intensity modulated proton therapy (IMPT), for high-risk prostate cancer patients with sentinel nodes in the pararectal region. Twenty high-risk prostate cancer patients were included in a prospective trial evaluating sentinel nodes on pelvic SPECT acquisition. To be eligible for the dosimetric study, patients had to present with pararectal sentinel nodes usually not included in the clinical target volume encompassing the pelvic lymph nodes. Radiotherapy-plans including the prostate, the seminal vesicles, and the pelvic lymph nodes with the pararectal sentinel nodes were optimized for 6 eligible patients. IMXT and IMPT were delivered with 7 and 3 beams respectively and VMAT with 2 arcs. Results were assessed with Dose-Volume Histograms and predictive normal tissue complication probabilities (NTCPs) models between the three competing treatment modalities aiming to deliver a total dose of 50.4 Gy in 1.8 Gy daily fractions. Target coverage was optimized with IMPT when compared to IMXT and VMAT. Coverage of the sentinel node was slightly better with IMXT (D-98% = 57.3 +/- 5.1 Gy) when compared with VMAT (D-98% = 56.2 +/- 4.1 Gy). The irradiation of rectal, bladder, small bowel, and femoral heads volumes was significantly reduced with IMPT when compared to IMXT and VMAT. NTCPs rates for rectal and bladder >= grade-3 late toxicity were better with IMPT (0.4 +/- 0.0% and 0.0 +/- 0.0%) compared with IMXT (4.6 +/- 3.3% and 1.4 +/- 1.1%), and VMAT (4.5 +/- 4.0% and 1.6 +/- 1.6%), respectively. Acceptable dose-volume distributions and low rectal and urinary NTCPs were estimated to geometrically complex pelvic volumes such as the ones proposed in this study using IMXT, VMAT and IMPT. IMPT succeeded, however, to propose the best physical and biological treatment plans compared to both X-ray derived plans.
引用
收藏
页码:181 / 189
页数:9
相关论文
共 50 条
  • [1] Treatment Efficiency of Volumetric Modulated Arc Therapy in Comparison With Intensity-Modulated Radiotherapy in the Treatment of Prostate Cancer
    Hall, William A.
    Fox, Timothy H.
    Jiang, Xiaojun
    Prabhu, Roshan S.
    Rossi, Peter J.
    Godette, Karen
    Jani, Ashesh B.
    JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY, 2013, 10 (02) : 128 - 134
  • [2] Volumetric modulated arc therapy versus intensity-modulated proton therapy in the postoperative irradiation of thymoma
    Davide Franceschini
    Luca Cozzi
    Mauro Loi
    Ciro Franzese
    Giacomo Reggiori
    Pietro Mancosu
    Alessandro Clivio
    Antonella Fogliata
    Marta Scorsetti
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 2267 - 2276
  • [3] Volumetric modulated arc therapy versus intensity-modulated proton therapy in the postoperative irradiation of thymoma
    Franceschini, Davide
    Cozzi, Luca
    Loi, Mauro
    Franzese, Ciro
    Reggiori, Giacomo
    Mancosu, Pietro
    Clivio, Alessandro
    Fogliata, Antonella
    Scorsetti, Marta
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (09) : 2267 - 2276
  • [4] Volumetric modulated arc therapy versus intensity-modulated proton therapy in the irradiation of infra diaphragmatic Hodgkin Lymphoma in female patients
    Rosenbrock, Johannes
    Baues, Christian
    Vasquez-Torres, Andres
    Clivio, Alessandro
    Fogliata, Antonella
    Borchmann, Peter
    Marnitz, Simone
    Cozzi, Luca
    ACTA ONCOLOGICA, 2022, 61 (01) : 81 - 88
  • [5] Volumetric modulated arc therapy versus intensity-modulated proton therapy in neoadjuvant irradiation of locally advanced oesophageal cancer
    Eren Celik
    Wolfgang Baus
    Christian Baues
    Wolfgang Schröder
    Alessandro Clivio
    Antonella Fogliata
    Marta Scorsetti
    Simone Marnitz
    Luca Cozzi
    Radiation Oncology, 15
  • [6] Volumetric modulated arc therapy versus intensity-modulated proton therapy in neoadjuvant irradiation of locally advanced oesophageal cancer
    Celik, Eren
    Baus, Wolfgang
    Baues, Christian
    Schroder, Wolfgang
    Clivio, Alessandro
    Fogliata, Antonella
    Scorsetti, Marta
    Marnitz, Simone
    Cozzi, Luca
    RADIATION ONCOLOGY, 2020, 15 (01)
  • [7] A Retrospective Planning Analysis Comparing Volumetric-Modulated Arc Therapy (VMAT) to Intensity-Modulated Radiation Therapy (IMRT) for Radiotherapy Treatment of Prostate Cancer
    Elith, Craig A.
    Cao, Fred
    Dempsey, Shane E.
    Findlay, Naomi
    Warren-Forward, Helen
    JOURNAL OF MEDICAL IMAGING AND RADIATION SCIENCES, 2013, 44 (02) : 79 - 86
  • [8] Comparison of volumetric-modulated arc therapy and intensity-modulated radiation therapy prostate cancer plans accounting for cold spots
    Tran Thi Thao Nguyen
    Arimura, Hidetaka
    Asamura, Ryosuke
    Hirose, Taka-aki
    Ohga, Saiji
    Fukunaga, Jun-ichi
    RADIOLOGICAL PHYSICS AND TECHNOLOGY, 2019, 12 (02) : 137 - 148
  • [9] Comparing Treatment Plan in All Locations of Esophageal Cancer Volumetric Modulated Arc Therapy versus Intensity-Modulated Radiotherapy
    Lin, Jang-Chun
    Tsai, Jo-Ting
    Chang, Chih-Chieh
    Jen, Yee-Min
    Li, Ming-Hsien
    Liu, Wei-Hsiu
    MEDICINE, 2015, 94 (17) : e750
  • [10] Intensity Modulated Radiotherapy and Volumetric Modulated Arc Therapy in the Treatment of Breast Cancer: An Updated Review
    Chang, Jee Suk
    Chang, Ji Hyun
    Kim, Nalee
    Kim, Yong Bae
    Shin, Kyung Hwan
    Kim, Kyubo
    JOURNAL OF BREAST CANCER, 2022, 25 (05) : 349 - 365